Why the study?
Do elevated triglyceride levels pose an increased risk for CHD?
Design
Review
Authors
Loading...
Supports atherogenic role of elevated triglycerides and low HDL; leaves open need for outcome trials before clinical adoption.
Key points are not available for this paper at this time.
Cindy Lamendola (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: